Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Reactive oxygen species modulators in pulmonary medicine

(2021) Reactive oxygen species modulators in pulmonary medicine. Current Opinion in Pharmacology. pp. 157-164. ISSN 1471-4892

[img] Text
Real-Time RT PCR Evaluation of the Xylitol Effect on the Expression of Streptococcus pneumoniae cpsB, cpsD and psaA Genes.pdf

Download (760kB)
[img] Text
Reactive oxygen species modulators in pulmonary medicine.pdf

Download (1MB)

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Adapted to effectively capture oxygen from inhaled air and deliver it to all other parts of the body, the lungs constitute the organ with the largest surface area. This makes the lungs more susceptible to airborne pathogens and pollutants that mediate pathologies through generation of reactive oxygen species (ROS). One pathological consequence of excessive levels of ROS production is pulmonary diseases that account for a large number of mortality and morbidity in the world. Of the various mechanisms involved in pulmonary disease pathogenesis, mitochondrial dysfunction takes prominent importance. Herein, we briefly describe the significance of oxidative stress caused by ROS in pulmonary diseases and some possible therapeutic strategies.

Item Type: Article
Keywords: COPD Oxidative stress Pulmonary fibrosis Reactive oxygen species oxidative stress free-radicals lung inflammation inhibition biomarkers diseases Pharmacology & Pharmacy
Page Range: pp. 157-164
Journal or Publication Title: Current Opinion in Pharmacology
Journal Index: ISI
Volume: 57
Identification Number: https://doi.org/10.1016/j.coph.2021.02.005
ISSN: 1471-4892
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/10061

Actions (login required)

View Item View Item